Accounts Receivable	12 Months Ended
	Dec. 31, 2021
Receivables [Abstract]
Accounts Receivable	Accounts Receivable    As of December 31, 2021, the Company had accounts receivable of $13.3 million which relates to royalty revenue from sales of NARCAN® and revenue from the contract with BARDA.